Tri-State blood donors have a new option. But not everyone is welcoming the addition. The American Red Cross has opened a permanent blood collection site in Cincinnati. The organization has been ...

There’s new progress in the battle against Alzheimer’s disease. About 1 in 9 US seniors has Alzheimer’s, the most common form of dementia, which slowly impairs memory, thinking skills and the ability ...

The tests have not been approved by federal regulators, but that hasn’t stopped patients from wanting them — and doctors from worrying. By Nina Agrawal In the spring of 2021, the cancer field was ...

A small study found that a blood test could identify whether someone had Chronic Fatigue Syndrome (CFS) with 92% accuracy. Because CFS and long COVID have some biological overlap, this research could ...

Cancer continues to be one of the world's top causes of death, partly because of delayed discovery of the disease. But according to a recently released study, a simple blood test may be able to ...

A team of scientists has developed a highly accurate blood test for Chronic Fatigue Syndrome. The test reads tiny DNA patterns that reveal the biological signature of the illness. For millions who’ve ...

Scientists are learning more about this leading complication of childbirth. Treatments are improving and doctors can test for biological markers that flag heightened risk. When you purchase through ...

Needle-free devices like TAP and Tasso offer painless blood collection, a benefit for the squeamish. These tests face challenges with sample size and accuracy compared to traditional methods. This ...

The U.S. Food and Drug Administration has cleared another blood test that could help doctors identify whether a patient's memory problems are likely caused by Alzheimer's disease. The new test, called ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer's disease and other causes of cognitive decline, providing a broader understanding of when the ...

Add Yahoo as a preferred source to see more of our stories on Google. Roche's Elecsys pTau181 test is the second blood-based biomarker test to receive FDA clearance for Alzheimer’s disease this year. ...